ESMO Consensus Conference on malignant lymphoma: General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

& the ESMO Lymphoma Consensus Conference Panel Members

Research output: Contribution to journalArticle

Abstract

The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aimof the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in thismanuscript.

Original languageEnglish
Pages (from-to)544-562
Number of pages19
JournalAnnals of Oncology
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Medical Oncology
Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Peripheral T-Cell Lymphoma
Literature
Mantle-Cell Lymphoma
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Manuscripts
B-Cell Lymphoma
Switzerland
Practice Guidelines
Quality of Life

Keywords

  • Consensus
  • Diagnosis
  • Elderly patient
  • Lymphoma
  • Quality of life
  • Treatment

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

ESMO Consensus Conference on malignant lymphoma : General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma. / & the ESMO Lymphoma Consensus Conference Panel Members.

In: Annals of Oncology, Vol. 29, No. 3, 01.03.2018, p. 544-562.

Research output: Contribution to journalArticle

@article{2efc051d3fd24157980f68860f7a7885,
title = "ESMO Consensus Conference on malignant lymphoma: General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma",
abstract = "The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aimof the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in thismanuscript.",
keywords = "Consensus, Diagnosis, Elderly patient, Lymphoma, Quality of life, Treatment",
author = "{& the ESMO Lymphoma Consensus Conference Panel Members} and C. Buske and M. Hutchings and M. Ladetto and V. Goede and U. Mey and P. Soubeyran and M. Spina and R. Stauder and M. Trněn{\'y} and U. Wedding and P. Fields and Martin Dreyling and Ferreri, {Andr{\'e}s J.M.} and Gianluca Gaidano and {Le Gouill}, Steven and Stefano Luminari and {de Nully Brown}, Peter and Michael Pfreundschuh and Christiane Pott and Norbert Schmitz and Balari, {Anna Sureda} and {van Imhoff}, Gustaaf and Jan Walewski and Alberto Zam{\`o} and Emanuele Zucca",
year = "2018",
month = "3",
day = "1",
doi = "10.1093/annonc/mdx413",
language = "English",
volume = "29",
pages = "544--562",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - ESMO Consensus Conference on malignant lymphoma

T2 - General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

AU - & the ESMO Lymphoma Consensus Conference Panel Members

AU - Buske, C.

AU - Hutchings, M.

AU - Ladetto, M.

AU - Goede, V.

AU - Mey, U.

AU - Soubeyran, P.

AU - Spina, M.

AU - Stauder, R.

AU - Trněný, M.

AU - Wedding, U.

AU - Fields, P.

AU - Dreyling, Martin

AU - Ferreri, Andrés J.M.

AU - Gaidano, Gianluca

AU - Le Gouill, Steven

AU - Luminari, Stefano

AU - de Nully Brown, Peter

AU - Pfreundschuh, Michael

AU - Pott, Christiane

AU - Schmitz, Norbert

AU - Balari, Anna Sureda

AU - van Imhoff, Gustaaf

AU - Walewski, Jan

AU - Zamò, Alberto

AU - Zucca, Emanuele

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aimof the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in thismanuscript.

AB - The European Society for Medical Oncology (ESMO) consensus conference on mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June 2015 in Lugano, Switzerland, and included a multidisciplinary panel of 25 leading experts. The aimof the conference was to develop recommendations on critical subjects difficult to consider in detail in the ESMO Clinical Practice Guidelines. The following areas were identified: (1) the elderly patient, (2) prognostic factors suitable for clinical use, and (3) the 'ultra-high-risk' group. Before the conference, the expert panel was divided into three working groups; each group focused on one of these areas in order to address clinically-relevant questions relating to that topic. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, each working group developed recommendations to address each of the four questions assigned to their group. These recommendations were presented to the entire panel and a consensus was reached. This consensus, which was further developed in continuous post-meeting discussions, formed the basis of three manuscripts, each covering one of the three key areas identified. This manuscript presents the consensus recommendations regarding the clinical management of elderly patients diagnosed with malignant lymphoma. Four clinically-relevant topics identified by the panel were: 1) how to define patient fitness, 2) assessing quality of life, 3) diagnostic work-up and 4) clinical management of elderly patients with lymphoma. Each of these key topics is addressed in the context of five different lymphoma entities, namely: CLL, follicular lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma and diffuse large B-cell lymphoma. Results, including a summary of evidence supporting each recommendation, are detailed in thismanuscript.

KW - Consensus

KW - Diagnosis

KW - Elderly patient

KW - Lymphoma

KW - Quality of life

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85046069858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046069858&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx413

DO - 10.1093/annonc/mdx413

M3 - Article

AN - SCOPUS:85046069858

VL - 29

SP - 544

EP - 562

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -